US drug approvals
13 approvals with a product on the US market
- Nintedanib Esylate ANDA219819 · approved 2 Apr 2026
- Tofacitinib Citrate ANDA218668 · approved 16 Dec 2024
- Pantoprazole Sodium ANDA216247 · approved 16 Jun 2023
- Omeprazole Magnesium ANDA216096 · approved 24 May 2022
- Vigabatrin ANDA215109 · approved 23 Sep 2021
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.